The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
The 40-second film brings children to the forefront of the narrative
Supported by Plan International, the partnership will help treat over 1,000 children annually
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
